Hydrocephalus after spontaneous subarachnoid hemorrhage

• Risk factors for surgery-related cerebral infarction after aneurysmal subarachnoid hemorrhage
• Grading Scores for Identifying Patients at Risk of Delayed Cerebral Ischemia and Neurological Outcome in Spontaneous Subarachnoid Hemorrhage: A Comparison of Receiver Operator Curve Analysis
• Rupture of a true anterior spinal artery aneurysm at its intracranial origin: a short report
• Effect of shunt-dependency on long-term outcome after aneurysmal subarachnoid hemorrhage: a post-hoc analysis of the EARLYDRAIN prospective patient cohort
• Augmented reality for external ventricular drain placement: Model alignment and integration software
• Cerebral Venous Thrombosis in Traumatic Brain Injury: A Population-Based Cross-Sectional Study of 640 Patients
• Aging Leads to Poor Outcome after Subarachnoid Hemorrhage through Exacerbating Early Brain Injury
• Aneurysmal Subarachnoid Hemorrhage Risk Assessment Model Identifies Patients for Safe Early Discharge at Day 15-The SAFE-SaH Score

Hydrocephalus after spontaneous subarachnoid hemorrhage (SAH) is a significant complication that can arise due to the accumulation of cerebrospinal fluid (CSF) in the brain’s ventricles or subarachnoid space. This condition requires careful spontaneous subarachnoid hemorrhage management to prevent worsening neurological impairment and to optimize recovery.

Obstructive Hydrocephalus: Blood from the SAH can cause clot formation and inflammation, leading to blockage of the CSF pathways. This can result in obstructive hydrocephalus, where CSF accumulates in the ventricles due to blocked flow.

Communicating Hydrocephalus: SAH can lead to an inflammatory response and fibrosis of the arachnoid granulations, impairing the absorption of CSF into the venous system. This results in communicating hydrocephalus, where the ventricles remain open but CSF accumulation occurs due to impaired reabsorption.

Clinical Assessment: Look for symptoms such as headache, nausea, vomiting, altered mental status, and changes in consciousness. Symptoms may vary depending on the severity and progression of hydrocephalus.

CT Scan: Provides initial assessment of ventricular size and can detect acute or chronic blood products. Enlarged ventricles may indicate hydrocephalus. MRI: Offers more detailed visualization of ventricular anatomy and can help differentiate between obstructive and communicating hydrocephalus.

Intracranial Pressure (ICP) Monitoring: Continuous monitoring can help assess the severity of hydrocephalus and guide treatment decisions.

Initial Management:

Medical Management: Initially, management may involve supportive measures, including managing ICP with hyperosmolar agents like mannitol or hypertonic saline, and optimizing blood pressure and fluid balance.

Neurocritical Care: Intensive monitoring in a neurocritical care setting to track changes in neurological status and ICP.

Ventriculostomy: Placement of an external ventricular drain (EVD) to drain excess CSF and relieve pressure. This is often used as a temporary measure and can help manage acute hydrocephalus.

Ventriculoperitoneal Shunt (VP Shunt): If hydrocephalus persists or becomes chronic, a VP shunt may be placed. This device diverts excess CSF from the ventricles to the peritoneal cavity for absorption.

Endoscopic Third Ventriculostomy (ETV): In some cases, particularly when there is a blockage in the ventricular outflow pathways, ETV can be performed to create a new CSF pathway and improve drainage.

Long-term Management:

Regular Follow-Up: Monitor for signs of shunt malfunction or infection and assess the effectiveness of the treatment.

Rehabilitation: Address any cognitive or physical impairments resulting from hydrocephalus and SAH through rehabilitation therapies.

Shunt Complications: Monitor for shunt infections, obstruction, or over-drainage, which can lead to further neurological issues.

Infection Prevention: Use sterile techniques during any procedures involving the CSF or shunt and monitor for signs of infection.

Hydrocephalus following spontaneous SAH requires a multidisciplinary approach:

Accurate Diagnosis: Using clinical evaluation and neuroimaging to determine the presence and type of hydrocephalus. Initial Management: Includes controlling ICP and using temporary measures like ventriculostomy. Surgical Intervention: For persistent or chronic cases, consider shunt placement or ETV. Ongoing Monitoring: Regular follow-up to manage complications and adjust treatment as needed. Rehabilitation: Address any functional impairments resulting from both SAH and hydrocephalus. Timely and effective management of hydrocephalus is crucial for improving outcomes and enhancing recovery in patients following spontaneous SAH.